Medicinal Cannabis in Orthopaedic Practice.

J Am Acad Orthop Surg · Apr 01 2020 · Review

Kleeman-Forsthuber LT, Dennis DA, Jennings JM

From the Porter Adventist Hospital, Denver, CO (Dr. Kleeman-Forsthuber, TN (Dr. Dennis)

Adult Reconstruction

SUMMARY — THE REDUCTIONReview finds evidence for medicinal cannabis in musculoskeletal conditions and arthroplasty pain management is too scant to support widespread use, calling for further research on efficacy and safety.
Abstract, as published

Cannabis has gained widespread public advocacy since its legalization in several states with recent evidence suggesting that its self-reported use has increased in patients undergoing a primary total joint arthroplasty. The endocannabinoid system has been proposed to play a role in decreasing the inflammatory cascade and enhancing pain management. For these reasons, interest has emerged in the orthopaedic community as a potential treatment or adjunct to treatment in many musculoskeletal conditions. However, the evidence to date is scant and precludes recommendations for its widespread use. Given the current paucity of evidence in the orthopaedic cohort, future research is warranted in this area to determine the efficacy and safety before endorsements can be made by orthopaedic surgeons.

Featured in the 2026-10-24 issue.

← Normal Axial Alignment of the Lower Extremity and Load-Bearin…The Role of Systemic Antifibrotic Agents on Patient and Surgi… →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.